Nova Patents
IL226238B

A subcutaneous pharmaceutical composition comprising suspension of crystalline form of 6-o-(4-dimethylaminoethoxy) cinnamoyl fumagillol

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

33 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
41165510United States of AmericaP
2011059966United States of AmericaW

Members33

Family members, oldest first
DocumentOfficeKind
CA2817199A1CanadaA1
WO2012064838A1World Intellectual Property Organization (WIPO)A1
US2012316233A1United States of AmericaA1
US8349891B2United States of AmericaB2
AU2011326566A1AustraliaA1
IL226238A0IsraelA0
SG190688A1SingaporeA1
MX2013005208AMexicoA
US2013197078A1United States of AmericaA1
EA201390675A1Eurasian Patent Organization (EAPO)A1
EP2638023A1European Patent Office (EPO)A1
CN103347870AChinaA
JP2013543867AJapanA
KR20140009994ARepublic of KoreaA
US8735447B2United States of AmericaB2
US2015018413A1United States of AmericaA1
NZ610569ANew ZealandA
UA111479C2UkraineC2
US9371312B2United States of AmericaB2
EP2638023B1European Patent Office (EPO)B1
AU2011326566B2AustraliaB2
US2017087119A1United States of AmericaA1
ES2610216T3SpainT3
CN106905267AChinaA
BR112013011550A2BrazilA2
US9827221B2United States of AmericaB2
JP6239977B2JapanB2
EA029941B1Eurasian Patent Organization (EAPO)B1
KR101892768B1Republic of KoreaB1
CA2817199CCanadaC
IL226238AIsraelA
IL226238BThis recordIsraelB
MY177039AMalaysiaA